ALPMF
Price
$9.85
Change
-$0.95 (-8.80%)
Updated
Oct 17 closing price
Capitalization
19.05B
JNJ
Price
$193.22
Change
+$1.10 (+0.57%)
Updated
Oct 17 closing price
Capitalization
465.34B
94 days until earnings call
Interact to see
Advertisement

ALPMF vs JNJ

Header iconALPMF vs JNJ Comparison
Open Charts ALPMF vs JNJBanner chart's image
Astellas Pharma
Price$9.85
Change-$0.95 (-8.80%)
Volume$100
Capitalization19.05B
Johnson & Johnson
Price$193.22
Change+$1.10 (+0.57%)
Volume$7.76M
Capitalization465.34B
ALPMF vs JNJ Comparison Chart in %
ALPMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALPMF vs. JNJ commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALPMF is a Hold and JNJ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (ALPMF: $9.85 vs. JNJ: $193.22)
Brand notoriety: ALPMF: Not notable vs. JNJ: Notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ALPMF: 3% vs. JNJ: 91%
Market capitalization -- ALPMF: $19.05B vs. JNJ: $465.34B
ALPMF [@Pharmaceuticals: Major] is valued at $19.05B. JNJ’s [@Pharmaceuticals: Major] market capitalization is $465.34B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $719.7B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $94.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALPMF’s FA Score shows that 1 FA rating(s) are green whileJNJ’s FA Score has 4 green FA rating(s).

  • ALPMF’s FA Score: 1 green, 4 red.
  • JNJ’s FA Score: 4 green, 1 red.
According to our system of comparison, JNJ is a better buy in the long-term than ALPMF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALPMF’s TA Score shows that 5 TA indicator(s) are bullish while JNJ’s TA Score has 4 bullish TA indicator(s).

  • ALPMF’s TA Score: 5 bullish, 3 bearish.
  • JNJ’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, ALPMF is a better buy in the short-term than JNJ.

Price Growth

ALPMF (@Pharmaceuticals: Major) experienced а -8.20% price change this week, while JNJ (@Pharmaceuticals: Major) price change was +1.31% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.16%. For the same industry, the average monthly price growth was +1.84%, and the average quarterly price growth was +19.16%.

Reported Earning Dates

JNJ is expected to report earnings on Jan 21, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (+0.16% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($465B) has a higher market cap than ALPMF($19B). ALPMF has higher P/E ratio than JNJ: ALPMF (52.65) vs JNJ (18.67). JNJ YTD gains are higher at: 36.826 vs. ALPMF (-0.122). ALPMF has higher annual earnings (EBITDA): 270B vs. JNJ (35.6B). ALPMF has more cash in the bank: 329B vs. JNJ (18.9B). JNJ has less debt than ALPMF: JNJ (50.8B) vs ALPMF (927B). ALPMF has higher revenues than JNJ: ALPMF (1.77T) vs JNJ (90.6B).
ALPMFJNJALPMF / JNJ
Capitalization19B465B4%
EBITDA270B35.6B758%
Gain YTD-0.12236.826-0%
P/E Ratio52.6518.67282%
Revenue1.77T90.6B1,956%
Total Cash329B18.9B1,741%
Total Debt927B50.8B1,825%
FUNDAMENTALS RATINGS
ALPMF vs JNJ: Fundamental Ratings
ALPMF
JNJ
OUTLOOK RATING
1..100
5045
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
18
Undervalued
PROFIT vs RISK RATING
1..100
10019
SMR RATING
1..100
10032
PRICE GROWTH RATING
1..100
6119
P/E GROWTH RATING
1..100
4685
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALPMF's Valuation (7) in the null industry is in the same range as JNJ (18) in the Pharmaceuticals Major industry. This means that ALPMF’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's Profit vs Risk Rating (19) in the Pharmaceuticals Major industry is significantly better than the same rating for ALPMF (100) in the null industry. This means that JNJ’s stock grew significantly faster than ALPMF’s over the last 12 months.

JNJ's SMR Rating (32) in the Pharmaceuticals Major industry is significantly better than the same rating for ALPMF (100) in the null industry. This means that JNJ’s stock grew significantly faster than ALPMF’s over the last 12 months.

JNJ's Price Growth Rating (19) in the Pharmaceuticals Major industry is somewhat better than the same rating for ALPMF (61) in the null industry. This means that JNJ’s stock grew somewhat faster than ALPMF’s over the last 12 months.

ALPMF's P/E Growth Rating (46) in the null industry is somewhat better than the same rating for JNJ (85) in the Pharmaceuticals Major industry. This means that ALPMF’s stock grew somewhat faster than JNJ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALPMFJNJ
RSI
ODDS (%)
Bullish Trend 3 days ago
55%
Bearish Trend 3 days ago
46%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
51%
Bearish Trend 3 days ago
38%
Momentum
ODDS (%)
Bearish Trend 3 days ago
59%
Bullish Trend 3 days ago
41%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
38%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
50%
Bullish Trend 3 days ago
43%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
50%
Bullish Trend 3 days ago
43%
Advances
ODDS (%)
Bullish Trend 24 days ago
52%
Bullish Trend 3 days ago
42%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
60%
Bearish Trend 3 days ago
50%
Aroon
ODDS (%)
Bullish Trend 6 days ago
40%
Bullish Trend 3 days ago
44%
View a ticker or compare two or three
Interact to see
Advertisement
ALPMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IYW197.170.69
+0.35%
iShares US Technology ETF
OLOXF4.30N/A
N/A
Deutsche Bank AG (London Branch)
XFIX52.12N/A
N/A
F/m Opportunistic Income ETF
ECF12.15-0.07
-0.57%
Ellsworth Growth and Income Fund Ltd
DBA26.54-0.19
-0.71%
Invesco DB Agriculture

ALPMF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALPMF has been loosely correlated with ALPMY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ALPMF jumps, then ALPMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPMF
1D Price
Change %
ALPMF100%
-8.81%
ALPMY - ALPMF
38%
Loosely correlated
+1.62%
JNJ - ALPMF
13%
Poorly correlated
+0.57%
GRFS - ALPMF
10%
Poorly correlated
-1.03%
AZNCF - ALPMF
8%
Poorly correlated
+1.04%
ABBV - ALPMF
5%
Poorly correlated
+1.19%
More

JNJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with PFE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
+0.57%
PFE - JNJ
59%
Loosely correlated
+1.16%
NVS - JNJ
54%
Loosely correlated
+0.50%
GSK - JNJ
49%
Loosely correlated
+0.32%
BIIB - JNJ
42%
Loosely correlated
+0.52%
BMY - JNJ
41%
Loosely correlated
+0.55%
More